Local allergic rhinitis in children

A BoÅ Ek1, B Ignasiak2, M Krupka1

  • 1Clinical Department of Internal Diseases, Dermatology and Allergology, Medical University of Silesia, Katowice, Poland.

Rhinology
|March 13, 2023
PubMed

Insights

Local allergic rhinitis (LAR) is a distinct nasal condition. This meta-analysis highlights the limited research on pediatric LAR, emphasizing the need for more studies in children.

Area of Science:

  • Allergy and immunology
  • Pediatric respiratory diseases

Background:

  • Local allergic rhinitis (LAR) is an endotype of rhinitis.
  • Limited data exists on the epidemiology, diagnosis, and treatment of LAR in pediatric populations.
  • Existing research on pediatric LAR is often derived from mixed-age cohorts.

Approach:

  • A meta-analysis was conducted focusing on pediatric patients.
  • Data was synthesized from studies involving young patients with LAR.
  • This approach addresses the scarcity of child-specific LAR research.

Key Points:

  • The study addresses the underrepresentation of children in LAR research.
  • It aggregates findings from existing studies to provide a clearer picture of pediatric LAR.
  • Highlights the need for dedicated research in this demographic.

Conclusions:

  • There is a significant gap in understanding local allergic rhinitis in children.
  • Further research specifically on pediatric LAR is crucial for accurate diagnosis and effective treatment.
  • This meta-analysis underscores the importance of pediatric-focused rhinitis research.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
28.1K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
314
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
391
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
496
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
374